Company intelligence / Profile preview

DanPET AB

Ownership: Private
Development stage: Phase 2

Overview

DanPET AB develops novel PET ligands and small molecule drugs targeting nicotinic and monoaminergic systems. Their compounds are used for imaging and potentially treating CNS disorders such as Alzheimer’s, Parkinson’s, ADHD, as well as CVD and cancer. Several radiotracers have demonstrated high specificity in preclinical models. Some assets have advanced to clinical trials through partnerships.

Therapeutic areas: OncologyPsychiatryCardiovascularNeurology
Modalities: PET ligands (positron emission tomography tracers)Small molecules (nicotinic and monoamine mechanism drugs)
Industry: Biotech

Drug pipeline

3 assets

AN317

Pre-clinical

Indications: Parkinson's disease

2 more assets in the full pipeline.

Request access →

Partnerships

Novandi Chemistry AB – commercialized products/radiochemicals catalog partnership.Initiator Pharma – co-founding involvement; clinical asset progression.Academic collaborations with Turku University/Abo Akademi University/Turku PET Center.

Beyond the preview

Go deeper on DanPET AB.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DanPET AB.

Explore the full profile